strong>Eisai Ltd., of Woodcliff Lake, N.J., said its epilepsy drug, Fycompa (perampanel), will be made available throughout the Middle East through a partnership with Hikma Pharmaceuticals plc, of London, with launches in in the region set to begin next year.